BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19368491)

  • 1. Characterization and expression of extrahepatic CYP2S1.
    Deb S; Bandiera SM
    Expert Opin Drug Metab Toxicol; 2009 Apr; 5(4):367-80. PubMed ID: 19368491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species difference in the regulation of cytochrome P450 2S1: lack of induction in rats by the aryl hydrocarbon receptor agonist PCB126.
    Wang B; Robertson LW; Wang K; Ludewig G
    Xenobiotica; 2011 Dec; 41(12):1031-43. PubMed ID: 21970748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2S1: a short review.
    Saarikoski ST; Rivera SP; Hankinson O; Husgafvel-Pursiainen K
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):62-9. PubMed ID: 16054184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel extrahepatic cytochrome P450s.
    Karlgren M; Miura S; Ingelman-Sundberg M
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):57-61. PubMed ID: 15987645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a new cytochrome P450 enzyme, CYP2S1, in rats: its regulation by aryl hydrocarbon receptor agonists.
    Deb S; Bandiera SM
    Toxicology; 2010 Jan; 267(1-3):91-8. PubMed ID: 19883719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW-610, NSC 721648) sensitivity in breast and colorectal cancer cells.
    Tan BS; Tiong KH; Muruhadas A; Randhawa N; Choo HL; Bradshaw TD; Stevens MF; Leong CO
    Mol Cancer Ther; 2011 Oct; 10(10):1982-92. PubMed ID: 21831963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1).
    Rylander T; Neve EP; Ingelman-Sundberg M; Oscarson M
    Biochem Biophys Res Commun; 2001 Feb; 281(2):529-35. PubMed ID: 11181079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of genetic polymorphisms of CYP2S1 in a Finnish Caucasian population.
    Saarikoski ST; Suitiala T; Holmila R; Impivaara O; Järvisalo J; Hirvonen A; Husgafvel-Pursiainen K
    Mutat Res; 2004 Oct; 554(1-2):267-77. PubMed ID: 15450424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of human cytochrome P450 2S1 using a synthetic gene-expressed protein in Escherichia coli.
    Bui PH; Hankinson O
    Mol Pharmacol; 2009 Nov; 76(5):1031-43. PubMed ID: 19713358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2S1 and CYP2W1 expression is associated with patient survival in breast cancer.
    Aiyappa-Maudsley R; Storr SJ; Rakha EA; Green AR; Ellis IO; Martin SG
    J Pathol Clin Res; 2022 Nov; 8(6):550-566. PubMed ID: 35902379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A transcriptomic approach to elucidate the physiological significance of human cytochrome P450 2S1 in bronchial epithelial cells.
    Madanayake TW; Lindquist IE; Devitt NP; Mudge J; Rowland AM
    BMC Genomics; 2013 Nov; 14():833. PubMed ID: 24279958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P4502S1: a novel monocyte/macrophage fatty acid epoxygenase in human atherosclerotic plaques.
    Frömel T; Kohlstedt K; Popp R; Yin X; Awwad K; Barbosa-Sicard E; Thomas AC; Lieberz R; Mayr M; Fleming I
    Basic Res Cardiol; 2013 Jan; 108(1):319. PubMed ID: 23224081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CYP2S1 and CYP2W1 in breast cancer epithelial cells and modulation of their expression by synthetic methoxy stilbenes.
    Szaefer H; Licznerska B; Cykowiak M; Baer-Dubowska W
    Pharmacol Rep; 2019 Dec; 71(6):1001-1005. PubMed ID: 31561186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2S1 is negatively regulated by corticosteroids in human cell lines.
    Bebenek IG; Solaimani P; Bui P; Hankinson O
    Toxicol Lett; 2012 Feb; 209(1):30-4. PubMed ID: 22155357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression, function and regulation of mouse cytochrome P450 enzymes: comparison with human P450 enzymes.
    Hrycay EG; Bandiera SM
    Curr Drug Metab; 2009 Dec; 10(10):1151-83. PubMed ID: 20166999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel dioxin-inducible cytochrome P450.
    Rivera SP; Saarikoski ST; Hankinson O
    Mol Pharmacol; 2002 Feb; 61(2):255-9. PubMed ID: 11809848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CYP2S1 in human hepatic stellate cells.
    Marek CJ; Tucker SJ; Koruth M; Wallace K; Wright MC
    FEBS Lett; 2007 Feb; 581(4):781-6. PubMed ID: 17280660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues.
    Pavek P; Dvorak Z
    Curr Drug Metab; 2008 Feb; 9(2):129-43. PubMed ID: 18288955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP2S1 depletion enhances colorectal cell proliferation is associated with PGE2-mediated activation of β-catenin signaling.
    Yang C; Li C; Li M; Tong X; Hu X; Yang X; Yan X; He L; Wan C
    Exp Cell Res; 2015 Feb; 331(2):377-86. PubMed ID: 25557876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases.
    Smith G; Wolf CR; Deeni YY; Dawe RS; Evans AT; Comrie MM; Ferguson J; Ibbotson SH
    Lancet; 2003 Apr; 361(9366):1336-43. PubMed ID: 12711469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.